Sandoz launches Tyruko in Germany for treatment of adults wi

Sandoz launches Tyruko in Germany for treatment of adults with RRMS

Sandoz has announced the launch of Tyruko, a biosimilar to treat relapsing remitting multiple sclerosis (RRMS), in Germany.

Related Keywords

Polpharma Biologics , Europe Rebecca Guntern , European Commission , Eastern European ,

© 2025 Vimarsana